Discriminatory Mentoring

The Scientist, May 16, 1994, page 3), the suggestion was made that the significance of the most precedent-setting aspect of Jensvold v. Shalala (that mentoring is covered under the discrimination law) for other women professionals is unclear. That is not correct. The most precedent-setting aspect of Jensvold v. Shalala to date came in the August 1993 summary judgment ruling on the case, not in the 1994 trial. The August 1993 ruling

Written byMargaret Jensvold
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The most precedent-setting aspect of Jensvold v. Shalala to date came in the August 1993 summary judgment ruling on the case, not in the 1994 trial. The August 1993 ruling found that mentoring is protected under Title VII of the 1964 Civil Rights Act. That ruling is unaffected by subsequent events.

On April 1, a unanimous jury of eight Maryland citizens ruled that David Rubinow's treatment of Margaret Jensvold at the National Institute of Mental Health constituted discriminatory mentoring, as well as sex discrimination and retaliation. This was precedent-setting in that it was the first time, to our knowledge, that a person has been found to have committed discriminatory mentoring.

When the Supreme Court ruled on April 26 that the Civil Rights Act of 1991 is not retroactive, the jury's decision in Jensvold v. Shalala reverted to an advisory ruling. The judge will now rule on the merits of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies